NSE BSE
fredun pharmaceuticals limited stock

Fredun Pharmaceuticals Limited Share Price

- - (%)
Sector: -

539730

FREDUN

img img img img
No Data Available

Fredun Pharmaceuticals Limited : Share Price Update


As of the latest trading session, Fredun Pharmaceuticals Limited share price is currently at 872.5, which is down by -6.84 from its previous closing. Today, the stock has fluctuated between 860.00 and 909.90. Over the past year, Fredun Pharmaceuticals Limited has achieved a return of -1.68 %. In the last month alone, the return has been 11.40 %.

Fredun Pharmaceuticals Limited Performance

Day Range

Low860.00 High909.90
892.00

52 Week Range

Low 650.00 High 1249.00
892.00

Open Price

899.95

Prev. Close

879.35

Volume (Shares)

12282.00

Total traded value

109.55

Upper Circuit

1077.95

Lower Circuit

718.65

Note: The current prices & values are delayed, Login to your account for live updates.

Fredun Pharmaceuticals Limited Fundamentals


(Standalone)

Market Cap (Cr) 409.90
PE Ratio (TTM) 26.37
Book Value / Share 259.28
Beta 0.89
ROE 13.15%
EPS (TTM) 33.35
Dividend Yield 0.00%
Net Profit Qtr (Cr) 5.06

Fredun Pharmaceuticals Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 117.21
Operating Expense 112.19
Net Profit 5.06
Net Profit Margin (%) 4.31
Earnings Per Share (EPS) 10.77
EBITDA 11.17
Effective Tax Rate (%) 13.35
Particulars DEC 2023 (Values in Cr)
Revenue 86.65
Operating Expense 81.25
Net Profit 4.22
Net Profit Margin (%) 4.87
Earnings Per Share (EPS) 8.99
EBITDA 10.52
Effective Tax Rate (%) 26.73
Particulars SEP 2023 (Values in Cr)
Revenue 81.48
Operating Expense 76.22
Net Profit 3.94
Net Profit Margin (%) 4.83
Earnings Per Share (EPS) 8.40
EBITDA 9.61
Effective Tax Rate (%) 31.71
Particulars JUN 2023 (Values in Cr)
Revenue 61.23
Operating Expense 57.96
Net Profit 2.40
Net Profit Margin (%) 3.91
Earnings Per Share (EPS) 5.24
EBITDA 7.60
Effective Tax Rate (%) 41.17
Particulars MAR 2023 (Values in Cr)
Revenue 79.73
Operating Expense 71.78
Net Profit 3.89
Net Profit Margin (%) 4.87
Earnings Per Share (EPS) 8.59
EBITDA 12.25
Effective Tax Rate (%) 51.43
Particulars MAR 2024 (Values in Cr)
Revenue 346.58
Operating Expense 327.62
Net Profit 15.62
Net Profit Margin (%) 4.50
Earnings Per Share (EPS) 33.32
EBITDA 38.90
Effective Tax Rate (%) 27.17
Particulars MAR 2023 (Values in Cr)
Revenue 274.34
Operating Expense 258.99
Net Profit 10.81
Net Profit Margin (%) 3.94
Earnings Per Share (EPS) 22.93
EBITDA 29.59
Effective Tax Rate (%) 38.26
Particulars MAR 2022 (Values in Cr)
Revenue 221.74
Operating Expense 217.48
Net Profit 6.34
Net Profit Margin (%) 2.85
Earnings Per Share (EPS) 14.29
EBITDA 15.43
Effective Tax Rate (%) 26.27
Particulars MAR 2021 (Values in Cr)
Revenue 131.55
Operating Expense 130.92
Net Profit 2.01
Net Profit Margin (%) 1.52
Earnings Per Share (EPS) 5.05
EBITDA 9.37
Effective Tax Rate (%) 37.07
Particulars MAR 2020 (Values in Cr)
Revenue 110.30
Operating Expense 110.78
Net Profit 1.90
Net Profit Margin (%) 1.72
Earnings Per Share (EPS) 4.77
EBITDA 8.78
Effective Tax Rate (%) 23.69
Particulars MAR 2023 (Values in Cr)
Book Value / Share 194.27
ROE % 13.15
ROCE % 18.11
Total Debt to Total Equity 0.85
EBITDA Margin 11.15
Particulars MAR 2022 (Values in Cr)
Book Value / Share 153.07
ROE % 11.41
ROCE % 12.90
Total Debt to Total Equity 0.83
EBITDA Margin 6.91
Particulars MAR 2021 (Values in Cr)
Book Value / Share 107.96
ROE % 4.76
ROCE % 9.34
Total Debt to Total Equity 0.88
EBITDA Margin 7.16
Particulars MAR 2020 (Values in Cr)
Book Value / Share 103.57
ROE % 4.73
ROCE % 10.16
Total Debt to Total Equity 0.67
EBITDA Margin 7.85
Particulars MAR 2019 (Values in Cr)
Book Value / Share 97.73
ROE % 14.58
ROCE % 19.63
Total Debt to Total Equity 0.48
EBITDA Margin 10.95
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.43
Total Assets 257.27
Total Liabilities 257.27
Total Equity 96.37
Share Outstanding 4532272
Price to Book Ratio 4.00
Return on Assets (%) 4.20
Return on Capital (%) 5.91
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.07
Total Assets 186.98
Total Liabilities 186.98
Total Equity 68.06
Share Outstanding 4432643
Price to Book Ratio 5.98
Return on Assets (%) 3.38
Return on Capital (%) 5.24
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.12
Total Assets 161.61
Total Liabilities 161.61
Total Equity 43.07
Share Outstanding 3989634
Price to Book Ratio 4.29
Return on Assets (%) 1.24
Return on Capital (%) 2.44
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.05
Total Assets 141.37
Total Liabilities 141.37
Total Equity 41.32
Share Outstanding 3989634
Price to Book Ratio 1.13
Return on Assets (%) 1.34
Return on Capital (%) 2.5
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 1.46
Total Assets 104.90
Total Liabilities 104.90
Total Equity 38.98
Share Outstanding 3989634
Price to Book Ratio 4.33
Return on Assets (%) 4.25
Return on Capital (%) 7.66
Particulars MAR 2023 (Values in Cr)
Net Income 10.75
Cash from Operations -14.40
Cash from Investing -9.40
Cash from Financing 25.17
Net change in Cash 1.36
Free Cash Flow -4.91
Particulars MAR 2022 (Values in Cr)
Net Income 6.31
Cash from Operations -2.38
Cash from Investing -4.14
Cash from Financing 7.46
Net change in Cash 0.94
Free Cash Flow 1.90
Particulars MAR 2021 (Values in Cr)
Net Income 2.01
Cash from Operations 0.16
Cash from Investing -1.38
Cash from Financing -0.71
Net change in Cash -1.93
Free Cash Flow 1.55
Particulars MAR 2020 (Values in Cr)
Net Income 2.34
Cash from Operations -10.61
Cash from Investing -1.49
Cash from Financing 13.72
Net change in Cash 1.59
Free Cash Flow -9.12
Particulars MAR 2019 (Values in Cr)
Net Income 6.17
Cash from Operations 1.30
Cash from Investing -5.25
Cash from Financing 4.42
Net change in Cash 0.01
Free Cash Flow 17.70
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 109.15 11.93 1.18 1142.70 71.00 / 148.95
CIPLA LTD 1420.05 26.93 4.29 114654.12 911.80 / 1519.00
FERMENTA BIOTECH LIMITED 160.95 0.00 1.65 473.69 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2023.85 53.46 22.26 34285.24 1265.00 / 2649.95
SANOFI INDIA LIMITED 8570.70 34.79 19.44 19738.32 6253.40 / 9370.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
Fredun Pharmaceuticals Limited 879.35 26.37 3.39 411.90 650.00 / 1249.00
AMRUTAJAN HEALTH LTD 749.30 49.23 8.26 2166.27 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5639.25 88.39 21.52 14098.13 3131.10 / 7208.00
BLISS GVS PHARMA LTD 109.15 15.08 1.15 1142.70 71.00 / 148.95
ABBOTT INDIA LIMITED 26545.40 46.96 15.25 56408.98 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 865.50
  • 26 Days 859.60
  • 10 Days 884.80
  • 50 Days 843.00
  • 12 Days 890.10
  • 100 Days 845.80
  • 20 Days 866.00
  • 200 Days 843.90
889.43
PIVOT
First Resistance 922.87
Second Resistance 947.43
Third Resistance 980.87
First Support 864.87
Second Support 831.43
Third Support 806.87
RSI 53.13
MACD 30.48
Commodity Channel Index (CCI) 25.03
ADX 17.13
Williams % R -65.16

Over 1 Month

down

11.40

Over 3 Months

down

-9.40

Over 6 Months

down

-0.40

Over 1 Year

down

-1.68

Over 3 Years

down

24.92

Over 5 Years

down

15.41

Fredun Pharmaceuticals Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Fredun Pharmaceuticals Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
51.07
Promoter Holdings
48.92
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Daulat Nariman Medhora Shareholding of Promoter and Promoter Group 1410898.0 29.88
Nariman Medhora Shareholding of Promoter and Promoter Group 719815.0 15.24
Fredun Nariman Medhora Shareholding of Promoter and Promoter Group 179172.0 3.79
Nikhil Kishorchandra Vora Public Shareholding 305476.0 0.0
Arun Kumar Mukherjee Public Shareholding 67794.0 0.0
Bank Of India Public Shareholding 75000.0 0.0

Fredun Pharmaceuticals Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-22 0.7 Final 2023-09-22 Equity shares 2021-09-16 0.7 Final 2021-09-18 Equity shares 2019-09-16 0.65 Final 2019-09-18 Equity shares 2018-09-18 0.6 Final 2018-09-21 Equity shares 2017-09-20 0.6 Final 2017-09-22 Equity shares 2016-04-11 0.6 Interim 2016-04-13 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Fredun Pharmaceuticals Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Fredun Pharmaceuticals Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Fredun Pharmaceuticals Ltd?

Answer Field

The share price of Fredun Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 872.5.

What is the Market Cap of Fredun Pharmaceuticals Ltd?

Answer Field

The market cap of Fredun Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 409.90 Cr. as of now.

What is the 52 Week High and Low of Fredun Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Fredun Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1249.00 and ₹ 650.00.

How to Buy Fredun Pharmaceuticals Ltd share?

Answer Field

You can trade in Fredun Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Fredun Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -1.68%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader